Market revenue in 2023 | USD 11,298.2 million |
Market revenue in 2030 | USD 24,496.6 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Hematopoietic stem cells (blood stem cells) |
Fastest growing segment | Mesenchymal Stem Cells |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hematopoietic Stem Cells (Blood Stem Cells), Mesenchymal Stem Cells, Neural Stem Cells, Epithelial/Skin Stem Cells, Other Adult Stem Cells |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adult stem cell market will help companies and investors design strategic landscapes.
Hematopoietic stem cells (blood stem cells) was the largest segment with a revenue share of 31.68% in 2023. Horizon Databook has segmented the Global adult stem cell market based on hematopoietic stem cells (blood stem cells), mesenchymal stem cells, neural stem cells, epithelial/skin stem cells, other adult stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global adult stem cell market , including forecasts for subscribers. This global databook contains high-level insights into Global adult stem cell market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account